ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiovascular Diseases Stem Cell Therapy Market Research Report 2026
Published Date: 2026-03-16
|
Report Code: QYRE-Auto-11N17739
Home | Market Reports | Health| Health Conditions
Global Cardiovascular Diseases Stem Cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Cardiovascular Diseases Stem Cell Therapy Market Research Report 2026

Code: QYRE-Auto-11N17739
Report
2026-03-16
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PHARMICELL
GenCell
Mesoblast Limited
BioCardia
Cedars Sinai
Heartseed
EmCell
BlueRock Therapeutics
Cellino Biotech
Stem Cells Transplant Institute
CCTRN
Help Therapeutics Co., Ltd.
Beijing Cellapy biotechnology Co., LTD
CardioCell

Cardiovascular Diseases Stem Cell Therapy Market

The global Cardiovascular Diseases Stem Cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Stem cells have the ability to treat sick veins when they touch the sick vein wall. They're also used to treat heart failure by turning into heart muscle cells if there is weakness in the heart muscles. They accelerates the post-operative recovery process by reinforcing the autoimmune system. They accelerate the treatment of heart muscle inflammation and inflammation. Endothelial stem cells (treating veins) are used for vessel walls. These stem cells are mostly derived from bone marrow. However, mesenchymal or fetal stem cells are used together to treat other factors affecting the disease.
The North American market for Cardiovascular Diseases Stem Cell Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cardiovascular Diseases Stem Cell Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cardiovascular Diseases Stem Cell Therapy in Preclinical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cardiovascular Diseases Stem Cell Therapy include Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cardiovascular Diseases Stem Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiovascular Diseases Stem Cell Therapy. The Cardiovascular Diseases Stem Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cardiovascular Diseases Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cardiovascular Diseases Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cardiovascular Diseases Stem Cell Therapy Market Report

Report Metric Details
Report Name Cardiovascular Diseases Stem Cell Therapy Market
Segment by Type
  • Autologous
  • Allogeneic
Segment by Application
  • Preclinical
  • Clinical Phase 1,2
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., Beijing Cellapy biotechnology Co., LTD, CardioCell, Heartseed, EmCell
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Cardiovascular Diseases Stem Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Cardiovascular Diseases Stem Cell Therapy Market report?

Ans: The main players in the Cardiovascular Diseases Stem Cell Therapy Market are Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., Beijing Cellapy biotechnology Co., LTD, CardioCell, Heartseed, EmCell

What are the Application segmentation covered in the Cardiovascular Diseases Stem Cell Therapy Market report?

Ans: The Applications covered in the Cardiovascular Diseases Stem Cell Therapy Market report are Preclinical, Clinical Phase 1,2

What are the Type segmentation covered in the Cardiovascular Diseases Stem Cell Therapy Market report?

Ans: The Types covered in the Cardiovascular Diseases Stem Cell Therapy Market report are Autologous, Allogeneic

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Cardiovascular Diseases Stem Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Perspective (2021–2032)
2.2 Global Cardiovascular Diseases Stem Cell Therapy Growth Trends by Region
2.2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Cardiovascular Diseases Stem Cell Therapy Market Dynamics
2.3.1 Cardiovascular Diseases Stem Cell Therapy Industry Trends
2.3.2 Cardiovascular Diseases Stem Cell Therapy Market Drivers
2.3.3 Cardiovascular Diseases Stem Cell Therapy Market Challenges
2.3.4 Cardiovascular Diseases Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiovascular Diseases Stem Cell Therapy Players by Revenue
3.1.1 Global Top Cardiovascular Diseases Stem Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Cardiovascular Diseases Stem Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cardiovascular Diseases Stem Cell Therapy Revenue
3.4 Global Cardiovascular Diseases Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Cardiovascular Diseases Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular Diseases Stem Cell Therapy Revenue in 2025
3.5 Global Key Players of Cardiovascular Diseases Stem Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Products and Applications
3.7 Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cardiovascular Diseases Stem Cell Therapy Breakdown Data by Type
4.1 Global Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Type (2027–2032)
5 Cardiovascular Diseases Stem Cell Therapy Breakdown Data by Application
5.1 Global Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cardiovascular Diseases Stem Cell Therapy Market Size (2021–2032)
6.2 North America Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2021–2026)
6.4 North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiovascular Diseases Stem Cell Therapy Market Size (2021–2032)
7.2 Europe Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2021–2026)
7.4 Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size (2021–2032)
9.2 Latin America Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmicell
11.1.1 Pharmicell Company Details
11.1.2 Pharmicell Business Overview
11.1.3 Pharmicell Cardiovascular Diseases Stem Cell Therapy Introduction
11.1.4 Pharmicell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.1.5 Pharmicell Recent Development
11.2 Gencell
11.2.1 Gencell Company Details
11.2.2 Gencell Business Overview
11.2.3 Gencell Cardiovascular Diseases Stem Cell Therapy Introduction
11.2.4 Gencell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.2.5 Gencell Recent Development
11.3 BlueRock Therapeutics
11.3.1 BlueRock Therapeutics Company Details
11.3.2 BlueRock Therapeutics Business Overview
11.3.3 BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Introduction
11.3.4 BlueRock Therapeutics Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.3.5 BlueRock Therapeutics Recent Development
11.4 Cellino Biotech
11.4.1 Cellino Biotech Company Details
11.4.2 Cellino Biotech Business Overview
11.4.3 Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Introduction
11.4.4 Cellino Biotech Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.4.5 Cellino Biotech Recent Development
11.5 Mesoblast
11.5.1 Mesoblast Company Details
11.5.2 Mesoblast Business Overview
11.5.3 Mesoblast Cardiovascular Diseases Stem Cell Therapy Introduction
11.5.4 Mesoblast Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.5.5 Mesoblast Recent Development
11.6 BioCardia
11.6.1 BioCardia Company Details
11.6.2 BioCardia Business Overview
11.6.3 BioCardia Cardiovascular Diseases Stem Cell Therapy Introduction
11.6.4 BioCardia Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.6.5 BioCardia Recent Development
11.7 Cedars-Sinai
11.7.1 Cedars-Sinai Company Details
11.7.2 Cedars-Sinai Business Overview
11.7.3 Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Introduction
11.7.4 Cedars-Sinai Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.7.5 Cedars-Sinai Recent Development
11.8 Stem Cells Transplant Institute
11.8.1 Stem Cells Transplant Institute Company Details
11.8.2 Stem Cells Transplant Institute Business Overview
11.8.3 Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Introduction
11.8.4 Stem Cells Transplant Institute Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.8.5 Stem Cells Transplant Institute Recent Development
11.9 CCTRN
11.9.1 CCTRN Company Details
11.9.2 CCTRN Business Overview
11.9.3 CCTRN Cardiovascular Diseases Stem Cell Therapy Introduction
11.9.4 CCTRN Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.9.5 CCTRN Recent Development
11.10 Help Therapeutics Co., Ltd.
11.10.1 Help Therapeutics Co., Ltd. Company Details
11.10.2 Help Therapeutics Co., Ltd. Business Overview
11.10.3 Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Introduction
11.10.4 Help Therapeutics Co., Ltd. Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.10.5 Help Therapeutics Co., Ltd. Recent Development
11.11 Beijing Cellapy biotechnology Co., LTD
11.11.1 Beijing Cellapy biotechnology Co., LTD Company Details
11.11.2 Beijing Cellapy biotechnology Co., LTD Business Overview
11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Introduction
11.11.4 Beijing Cellapy biotechnology Co., LTD Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.11.5 Beijing Cellapy biotechnology Co., LTD Recent Development
11.12 CardioCell
11.12.1 CardioCell Company Details
11.12.2 CardioCell Business Overview
11.12.3 CardioCell Cardiovascular Diseases Stem Cell Therapy Introduction
11.12.4 CardioCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.12.5 CardioCell Recent Development
11.13 Heartseed
11.13.1 Heartseed Company Details
11.13.2 Heartseed Business Overview
11.13.3 Heartseed Cardiovascular Diseases Stem Cell Therapy Introduction
11.13.4 Heartseed Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.13.5 Heartseed Recent Development
11.14 EmCell
11.14.1 EmCell Company Details
11.14.2 EmCell Business Overview
11.14.3 EmCell Cardiovascular Diseases Stem Cell Therapy Introduction
11.14.4 EmCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
11.14.5 EmCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
PHARMICELL
GenCell
Mesoblast Limited
BioCardia
Cedars Sinai
Heartseed
EmCell
BlueRock Therapeutics
Cellino Biotech
Stem Cells Transplant Institute
CCTRN
Help Therapeutics Co., Ltd.
Beijing Cellapy biotechnology Co., LTD
CardioCell
List of Tables
 Table 1. Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Autologous
 Table 3. Key Players of Allogeneic
 Table 4. Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2021–2026)
 Table 8. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2027–2032)
 Table 10. Cardiovascular Diseases Stem Cell Therapy Market Trends
 Table 11. Cardiovascular Diseases Stem Cell Therapy Market Drivers
 Table 12. Cardiovascular Diseases Stem Cell Therapy Market Challenges
 Table 13. Cardiovascular Diseases Stem Cell Therapy Market Restraints
 Table 14. Global Cardiovascular Diseases Stem Cell Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Players (2021–2026)
 Table 16. Global Top Cardiovascular Diseases Stem Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cardiovascular Diseases Stem Cell Therapy Revenue, 2025
 Table 17. Ranking of Global Top Cardiovascular Diseases Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Cardiovascular Diseases Stem Cell Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Products and Applications
 Table 21. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. Pharmicell Company Details
 Table 47. Pharmicell Business Overview
 Table 48. Pharmicell Cardiovascular Diseases Stem Cell Therapy Product
 Table 49. Pharmicell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 50. Pharmicell Recent Development
 Table 51. Gencell Company Details
 Table 52. Gencell Business Overview
 Table 53. Gencell Cardiovascular Diseases Stem Cell Therapy Product
 Table 54. Gencell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 55. Gencell Recent Development
 Table 56. BlueRock Therapeutics Company Details
 Table 57. BlueRock Therapeutics Business Overview
 Table 58. BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Product
 Table 59. BlueRock Therapeutics Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 60. BlueRock Therapeutics Recent Development
 Table 61. Cellino Biotech Company Details
 Table 62. Cellino Biotech Business Overview
 Table 63. Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Product
 Table 64. Cellino Biotech Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 65. Cellino Biotech Recent Development
 Table 66. Mesoblast Company Details
 Table 67. Mesoblast Business Overview
 Table 68. Mesoblast Cardiovascular Diseases Stem Cell Therapy Product
 Table 69. Mesoblast Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 70. Mesoblast Recent Development
 Table 71. BioCardia Company Details
 Table 72. BioCardia Business Overview
 Table 73. BioCardia Cardiovascular Diseases Stem Cell Therapy Product
 Table 74. BioCardia Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 75. BioCardia Recent Development
 Table 76. Cedars-Sinai Company Details
 Table 77. Cedars-Sinai Business Overview
 Table 78. Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Product
 Table 79. Cedars-Sinai Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 80. Cedars-Sinai Recent Development
 Table 81. Stem Cells Transplant Institute Company Details
 Table 82. Stem Cells Transplant Institute Business Overview
 Table 83. Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Product
 Table 84. Stem Cells Transplant Institute Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 85. Stem Cells Transplant Institute Recent Development
 Table 86. CCTRN Company Details
 Table 87. CCTRN Business Overview
 Table 88. CCTRN Cardiovascular Diseases Stem Cell Therapy Product
 Table 89. CCTRN Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 90. CCTRN Recent Development
 Table 91. Help Therapeutics Co., Ltd. Company Details
 Table 92. Help Therapeutics Co., Ltd. Business Overview
 Table 93. Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Product
 Table 94. Help Therapeutics Co., Ltd. Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 95. Help Therapeutics Co., Ltd. Recent Development
 Table 96. Beijing Cellapy biotechnology Co., LTD Company Details
 Table 97. Beijing Cellapy biotechnology Co., LTD Business Overview
 Table 98. Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Product
 Table 99. Beijing Cellapy biotechnology Co., LTD Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 100. Beijing Cellapy biotechnology Co., LTD Recent Development
 Table 101. CardioCell Company Details
 Table 102. CardioCell Business Overview
 Table 103. CardioCell Cardiovascular Diseases Stem Cell Therapy Product
 Table 104. CardioCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 105. CardioCell Recent Development
 Table 106. Heartseed Company Details
 Table 107. Heartseed Business Overview
 Table 108. Heartseed Cardiovascular Diseases Stem Cell Therapy Product
 Table 109. Heartseed Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 110. Heartseed Recent Development
 Table 111. EmCell Company Details
 Table 112. EmCell Business Overview
 Table 113. EmCell Cardiovascular Diseases Stem Cell Therapy Product
 Table 114. EmCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 115. EmCell Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Cardiovascular Diseases Stem Cell Therapy Picture
 Figure 2. Global Cardiovascular Diseases Stem Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Type: 2025 vs 2032
 Figure 4. Autologous Features
 Figure 5. Allogeneic Features
 Figure 6. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Preclinical Case Studies
 Figure 9. Clinical Phase 1,2 Case Studies
 Figure 10. Cardiovascular Diseases Stem Cell Therapy Report Years Considered
 Figure 11. Global Cardiovascular Diseases Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Cardiovascular Diseases Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region: 2025 vs 2032
 Figure 14. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Players in 2025
 Figure 15. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Cardiovascular Diseases Stem Cell Therapy Revenue in 2025
 Figure 17. North America Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 19. United States Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 23. Germany Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2021–2032)
 Figure 31. China Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 39. Mexico Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 43. Israel Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Pharmicell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 47. Gencell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 48. BlueRock Therapeutics Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 49. Cellino Biotech Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 50. Mesoblast Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 51. BioCardia Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 52. Cedars-Sinai Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 53. Stem Cells Transplant Institute Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 54. CCTRN Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 55. Help Therapeutics Co., Ltd. Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 56. Beijing Cellapy biotechnology Co., LTD Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 57. CardioCell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 58. Heartseed Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 59. EmCell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2021–2026)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Cardiology Stem Cells Market Research Report 2024
Global Stem Cell Therapy for Pets Market Research Report 2024
Global Cell Therapy Regenerative Medicine Market Research Report 2025
Placental Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Therapy Market Insights Forecast to 2030
Global Cardiac Disease Stem Cell Therapy Market Research Report 2024
Hematopoietic Stem Cells Transplantation Market
Global Animal Stem Cell Therapy Market Research Report 2025
Global Pet Stem Cells Market Insights Forecast to 2030
Global Stem Cell Treatments Market Insights Forecast to 2030
Global Canine Stem Cell Therapy Market Research Report 2024
Transplantation of Hematopoietic Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transplantation of Multipotent Hematopoietic Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematopoietic Stem Cells Transplantation Consumables and Storage Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Umbilical Cord Blood Stem Cell Bank Market Research Report 2024
Global Mesenchymal Stem Cell Drugs Market Research Report 2024
Global Stem Cell Therapy for Infertility Market Research Report 2024
Global Stem Cell Services Market Insights Forecast to 2030
Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2024
Global Mesenchymal Stem Cell Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions